Login

Ben McMillan, CIO and founder of IDX Digital Assets, discusses market insights in an interview with CNBC. 00:10:00

Share On Facebook Share On Twitter

Ben McMillan, CIO of IDX Digital Assets,

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Data Respons Hackathon 2023 | Kenneth Ragnvaldsen, CEO, Data Respons ASADAT:OSL
00:10:00
Cavidan Karaca on Company Activities, Investments, and Public Offering Insights | Cavidan Karaca, CEO , Kimteks Poliuretan Sanayi ve Ticaret A.Ş.
00:10:00
Interview with Award Winner on Challenges in M&A and Finance
00:00:00
Sébastien Peltier, CEO of Valbiotis
00:10:00
Arezzo's Journey to Success: Insights from CEO Alexandre Birman | Alexandre Birman, CEO, Arezzo Industria e Comercio SA.
00:10:00
Nuclear Reactor Technology Vital for Poland's Future Energy Mix, Predicts Enea SA President | Paweł Majewski, CEO, Enea SA.
00:10:00
Building Trust: The Key to Successful Client Relationships
00:10:00
Partnership with Shoppers Drug Mart to Enhance Medical Cannabis Access and Patient Care| Aras Azadian, CEO, Avicanna Inc.
00:10:00
Keith McKnight of Group 6 Metals Shares Insights on High-Grade Tungsten Production from Dolphin Mine | Keith McKnight, CEO , Group 6 Metals Ltd.
00:10:00
Lotus Resources Presentation on Uranium Projects at One-to-One Conference
00:10:00
Chuck Grom, analyst at Gordon Haskett, explains his decision to downgrade Macy's stock and the challenges facing the retail sector on "Squawk on the Street."
00:10:00
investment firm that focuses on cross-border financial investment|Michael Nicklas,Managing Partner,Valor Capital Group

© 2017 - Neuhu+